Summary & Overview
CPT 51715: Endoscopic Urethral/Bladder Neck Injection for Incontinence
CPT code 51715 represents endoscopic injection of natural or synthetic bulking material into the submucosal tissue of the urethra and/or bladder neck to treat urinary incontinence. This minimally invasive urologic procedure is used to improve urethral coaptation and reduce stress urinary leakage when conservative measures are insufficient. Nationally, it is a relevant ambulatory surgical procedure in urology and gynecologic practice given the prevalence of urinary incontinence and the demand for office- and outpatient-based interventions.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical intent of the code, typical sites of service, and common billing modifiers associated with outpatient endoscopic urologic procedures. The publication also summarizes payer coverage patterns and benchmarks where available, highlights relevant coding and documentation considerations, and situates the procedure within broader clinical care pathways for urinary incontinence.
This guide is intended for coding professionals, billing managers, and clinical administrators seeking a clear, national-level summary of CPT code 51715, its clinical context, and operational considerations for outpatient urologic services.
Billing Code Overview
CPT code 51715 describes an endoscopic injectable procedure in which a provider injects a natural or synthetic material into the submucosal tissue of the urethra and/or bladder neck to treat urinary incontinence. The procedure is performed using an endoscope, a stiff or flexible tubular instrument with a camera at its distal end, enabling visualization of the urethral and bladder neck mucosa during targeted submucosal injection.
-
Service type: Endoscopic urethral/bladder neck submucosal injection for treatment of urinary incontinence
-
Typical site of service: Ambulatory surgery center or hospital outpatient department; may also be performed in an endoscopy suite or specialized urology clinic equipped for endoscopic procedures
Clinical & Coding Specifications
Clinical Context
A typical patient is a postmenopausal woman presenting with stress urinary incontinence characterized by urine leakage with coughing, laughing, or exertion. Conservative measures (pelvic floor physical therapy, pessary, behavioral modification) have been tried without adequate symptom control. After urologic or urogynecologic evaluation including history, physical exam, urinalysis, and assessment of post-void residual, the provider elects to perform endoscopic urethral bulking using a natural or synthetic submucosal injectable (urethral bulking agent) to reduce urethral hypermobility and improve coaptation of the bladder neck and mid‑urethra.
The clinical workflow: the patient arrives to an ambulatory surgery center or outpatient procedure room; informed consent is confirmed; pre-procedure antibiotics may be given per facility protocol; local, regional, or monitored anesthesia is administered; a cystoscope or flexible endoscope is introduced transurethrally; the provider injects the bulking material into submucosal tissue at the bladder neck and/or mid-urethra under direct visualization; hemostasis and irrigation are performed; catheterization is used per operator preference and usually removed same day; discharge instructions address voiding pattern, signs of infection, and follow-up for symptom evaluation and possible repeat injection.
Typical site of service: outpatient ambulatory surgery center or hospital outpatient department. Service type: minor, non‑invasive endoscopic therapeutic procedure performed by a urologist or urogynecologist.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|